WESTFORD, Mass., Aug. 28, 2012 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that management will be presenting at two upcoming investor conferences.
- On Tuesday, September 11 at 10:25 a.m. (ET), President and Chief Executive Officer Michael Davin and Executive Vice President, Treasurer and Chief Financial Officer Timothy Baker will present at the Rodman & Renshaw Annual Global Investment Conference in New York City.
- On Thursday, September 20 at 3:30 p.m. (ET), Executive Vice President, Treasurer and Chief Financial Officer Timothy Baker will present at the UBS Global Life Sciences Conference in New York City.
About Cynosure, Inc. Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce the appearance of cellulite and treat Onychomycosis. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Q-switched, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.
Contact:Scott SolomonVice PresidentSharon Merrill Associates, Inc.617.542.5300 email@example.com SOURCE Cynosure, Inc.